Moreover, experimental validation supported the involvement of HERC6, IFI44L, and RSAD2 in SLE-related cardiac dysfunction, with HERC6 showing the most pronounced upregulation in doxorubicin-treated H9C2 cardiomyocytes. The gene discussed is IFI44L; the disease is systemic lupus erythematosus.